← Back to patent-cliff list
Anticoagulation & Thrombosis
61 · drugs37 · with routes28 · with on-sale intermediates
61 patent-cliff drugs in Anticoagulation & Thrombosis (classified by indication keywords and explicit molecule lists from our structured data), 37 with recorded synthesis routes and 28 with on-sale intermediates. Every "Available" badge links to real listings for RFQ.
| Drug | Tier | Expiry | Indications | Routes | CAS count | Available |
|---|---|---|---|---|---|---|
| Ticagrelor | B · Position early | 2029 | Stroke, Acute coronary syndrome, Myocardial infarction | 5 | 55 | Available ×55 |
| Rivaroxaban | A · Act now | 2026 | Pulmonary embolism, Stroke, Congenital heart defect | 6 | 46 | Available ×46 |
| Dabigatran Etexilate Mesylate | B · Position early | - | Venous thromboembolism, Embolism, Stroke | 7 | 31 | Available ×31 |
| Apixaban | A · Act now | 2028 | Pulmonary embolism, Venous thrombosis, Paget-Schroetter syndrome | 7 | 30 | Available ×30 |
| Cangrelor Tetrasodium | C · Watch | - | Coronary thrombosis, Myocardial infarction, Thrombosis | 2 | 21 | Available ×21 |
| Rilzabrutinib | C · Watch | - | Immune thrombocytopenic purpura | 1 | 14 | Available ×14 |
| Avatrombopag Maleate | C · Watch | 2030 | Thrombocytopenia, Immune thrombocytopenic purpura, Liver disease | 1 | 11 | Available ×11 |
| Pacritinib Citrate | C · Watch | - | Myelofibrosis | 2 | 15 | Available ×7 |
| Fostamatinib disodium hexahydrate | C · Watch | - | Immune thrombocytopenic purpura, Thrombocytopenia | 1 | 6 | Available ×6 |
| Itacitinib | C · Watch | - | Diffuse large B-cell lymphoma, Myeloproliferative neoplasm, Acute lymphoblastic leukaemia | 2 | 33 | Available ×5 |
| Clarithromycin/Rabeprazole Sodium/Amoxicillin | C · Watch | - | Marginal zone B-cell lymphoma, Duodenal ulcer, Immune thrombocytopenic purpura | 20 | 46 | Available ×4 |
| Rabeprazole Sodium/Metronidazole/Amoxicillin | C · Watch | - | Duodenal ulcer, Immune thrombocytopenic purpura, Gastric ulcer | 13 | 39 | Available ×4 |
| Edoxaban Tosilate Hydrate | B · Position early | 2028 | Pulmonary embolism, Venous thromboembolism, Stroke | 6 | 37 | Available ×4 |
| Tirofiban Hydrochloride Hydrate | C · Watch | - | Unstable angina, Myocardial infarction, Coronary thrombosis | 2 | 21 | Available ×3 |
| Momelotinib Dihydrochloride | C · Watch | - | Myelofibrosis, Myeloproliferative neoplasm, Splenomegaly | 1 | 7 | Available ×3 |
| Zifaxaban | C · Watch | - | Venous thrombosis, Pulmonary embolism | 1 | 9 | Available ×3 |
| AZD-6482 | C · Watch | - | Ischaemic stroke, Stroke, Thrombosis | 1 | 11 | Available ×3 |
| Orelabrutinib | C · Watch | - | Marginal zone B-cell lymphoma, Mantle cell lymphoma, Chronic lymphocytic leukaemia | 3 | 20 | Available ×2 |
| Gandotinib | C · Watch | - | Haematological malignancy, Myelofibrosis, Myeloproliferative neoplasm | 3 | 26 | Available ×2 |
| Rosuvastatin Calcium | B · Position early | - | Homozygous familial hypercholesterolaemia, Heterozygous familial hypercholesterolaemia, Hyperlipoproteinaemia type III | 5 | 51 | Available ×1 |
| Anagrelide Hydrochloride Hydrate | C · Watch | - | Essential thrombocythaemia, Myeloproliferative neoplasm | 5 | 27 | Available ×1 |
| Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract | C · Watch | - | Arterial occlusive disease, Cerebrovascular disease, Embolism and thrombosis | 4 | 32 | Available ×1 |
| Ticlopidine Hydrochloride | C · Watch | - | Thromboembolism, Arterial occlusive disease, Transient ischaemic attack | 4 | 32 | Available ×1 |
| Macitentan | B · Position early | - | Pulmonary arterial hypertension | 2 | 18 | Available ×1 |
| Idasanutlin | C · Watch | - | Solid tumour, Acute myeloid leukaemia, Polycythaemia vera | 2 | 14 | Available ×1 |
| Lusutrombopag | C · Watch | 2031 | Thrombocytopenia | 1 | 12 | Available ×1 |
| Chidamide | C · Watch | - | Diffuse large B-cell lymphoma, T-cell leukaemia, Breast cancer | 1 | 6 | Available ×1 |
| Cevidoplenib | C · Watch | - | Immune thrombocytopenic purpura, Rheumatoid arthritis | 1 | 6 | Available ×1 |
| Fondaparinux Sodium | C · Watch | - | Pulmonary embolism, Venous thrombosis, Myocardial infarction | 5 | 43 | - |
| Betrixaban | C · Watch | 2028 | Venous thromboembolism, Hepatic function decline, Atrial fibrillation | 2 | 10 | - |
| Panobinostat Lactate | C · Watch | - | Multiple myeloma | 2 | 11 | - |
| Fedratinib | C · Watch | - | Myelofibrosis, Splenomegaly | 1 | 4 | - |
| Riociguat | B · Position early | - | Pulmonary arterial hypertension, Pulmonary hypertension, Chronic thromboembolic pulmonary hypertension | 1 | 10 | - |
| Bevifibatide Citrate | C · Watch | - | Acute coronary syndrome | 1 | 8 | - |
| Lenumlostat hydrochloride | C · Watch | - | Myelofibrosis, Essential thrombocythaemia, Polycythaemia vera | 1 | 9 | - |
| Veliparib Hydrochloride | C · Watch | - | Glioblastoma, 神经胶质肉瘤, Metastatic breast cancer | 1 | 6 | - |
| Tasquinimod | C · Watch | - | Myelofibrosis, Essential thrombocythaemia, Polycythaemia vera | 1 | 7 | - |
| Defibrotide sodium | C · Watch | - | Hepatic veno-occlusive disease | - | - | - |
| Clopidogrel Bisulfate/Aspirin | C · Watch | - | Atherosclerosis, Acute coronary syndrome, Thrombosis | - | - | - |
| Keverprazan Hydrochloride | C · Watch | - | Helicobacter pylori infection, Duodenal ulcer, Peptic oesophagitis | - | - | - |
| Dermatan sulfate | C · Watch | - | Venous thromboembolism, Thrombosis, Thrombocytopenia | - | - | - |
| Ardeparin | C · Watch | - | Pulmonary embolism, Venous thrombosis | - | - | - |
| Flonoltinib maleate | C · Watch | - | Myelofibrosis, 丝虫病, 红细胞增多症 | - | - | - |
| LNK-01002 | C · Watch | - | Myelofibrosis, Myeloproliferative neoplasm, Haematological malignancy | - | - | - |
| H001 | C · Watch | - | Venous thromboembolism, Shock, Prostate cancer | - | - | - |
| TAX-2 | C · Watch | - | Solid tumour, Thrombosis | - | - | - |
| CG-0255 (PO) | C · Watch | - | Cardiac and vascular disorders, Coronary artery disease, Peripheral arterial disease | - | - | - |
| DT-678 | C · Watch | - | ST段抬高型心肌梗死, 非ST段抬高型心肌梗死, Ischaemic stroke | - | - | - |
| Vortosiran | C · Watch | - | Coronary artery lesion, Coronary artery disease, Venous thrombosis | - | - | - |
| XH-5102 | C · Watch | - | Myeloproliferative neoplasm, Myelofibrosis, Chronic myeloid leukaemia | - | - | - |
| Iadademstat | C · Watch | - | Acute myeloid leukaemia, Myelofibrosis, Myeloproliferative neoplasm | - | - | - |
| Valproic acid (Cereno Scientific) | C · Watch | - | Pulmonary arterial hypertension, Thrombosis | - | - | - |
| JBI-802 | C · Watch | - | Non-small cell lung cancer, Myeloproliferative neoplasm, Myelodysplastic syndrome | - | - | - |
| Angiontensin(1-7) | C · Watch | - | 冠状病毒感染, COVID-19, Traumatic brain injury | - | - | - |
| Dimolegin | C · Watch | - | Venous thromboembolism, COVID-19 | - | - | - |
| Amsulostat | C · Watch | - | Myelofibrosis, Essential thrombocythaemia, Polycythaemia vera | - | - | - |
| MT-1002(Shaanxi Micot Technology) | C · Watch | - | ST段抬高型心肌梗死, Unstable angina, 非ST段抬高型心肌梗死 | - | - | - |
| Fesomersen | C · Watch | - | Nephropathy, Thromboembolism | - | - | - |
| Zetomipzomib | C · Watch | - | Autoimmune hepatitis, 多发性肌炎, 皮肌炎 | - | - | - |
| Isoquercetin | C · Watch | - | Venous thromboembolism, Pancreatic cancer, Ovarian cancer | - | - | - |
| Dexamethasone intravitreal implant (Aerie Pharmaceuticals) | C · Watch | - | Postoperative pain, 足底筋膜炎, Chemotherapy-induced nausea and vomiting | - | - | - |
Frequently asked questions
Which patent-cliff drugs in Anticoagulation & Thrombosis are worth tracking?
61 drugs related to Anticoagulation & Thrombosis are tracked on this site, 37 of them with recorded synthesis routes. See the table above and open each drug profile for routes and intermediates.
Where can I source Anticoagulation & Thrombosis intermediates?
Key intermediates of 28 drugs in this table are available through the Unibest supply network; for the rest, submit an RFQ per CAS on the intermediate profile pages.
Where can I check patent expiry for these drugs?
Each drug profile shows the public expiry year; yearly overviews are available at /patent-cliff/expires/<year>.
Source: cross-verified structured fields · Classification: indication keywords + explicit molecule lists · 2026-10-22